| 21-May-13 01:04PM | SAVIENT PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 20-May-13 02:50PM | SVNT July Options Begin Trading at TheStreet |
| 19-May-13 11:40AM | 3 Pharmaceutical Stock Earnings Snapshots at Wall St. Cheat Sheet |
| 17-May-13 05:26AM | Savient downgraded to Market Perform from Outperform at William Blair theflyonthewall.com |
| 15-May-13 08:37AM | Savient Pharmaceuticals Earnings: Everything You Must Know Now at Wall St. Cheat Sheet -14.71% |
| 07:09AM | InPlay: Savient Pharma misses by $0.03, misses on revs Briefing.com |
| 07:00AM | Savient Pharmaceuticals Reports First Quarter 2013 Financial Results PR Newswire |
| 12:13AM | SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online |
| 12:11AM | SAVIENT PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 10-Apr-13 11:03PM | SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or EDGAR Online |
| 05-Apr-13 01:04PM | SAVIENT PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 01-Apr-13 09:16AM | SAVIENT PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 25-Mar-13 03:32PM | Savient Pharmaceuticals: Is Anything Left? at Seeking Alpha |
| 23-Mar-13 01:45PM | Did These 5 Stocks Miss or Beat Analyst Expectations? at Wall St. Cheat Sheet |
| 21-Mar-13 12:03AM | SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online |
| 20-Mar-13 07:35PM | New Star Analyst Rankings for Savient Pharmaceuticals Inc StarMine |
| 19-Mar-13 01:56PM | Savient Pharma falls on slower gout drug growth AP -14.94% |
| 12:26PM | Savient Pharmaceuticals' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 10:18AM | Savient Pharmaceuticals Earnings: Heres Why Investors are Not Happy Now at Wall St. Cheat Sheet |
| 07:00AM | Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results PR Newswire |
| 18-Mar-13 03:24PM | Companies reporting Before the Market Open on Tuesday, March 19 at theflyonthewall.com |
| 26-Feb-13 08:30AM | Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2012 Financial Results Conference Call on Tuesday, March 19, 2013 PR Newswire |
| 19-Feb-13 08:34AM | Sobi, Savient announce co-promotion agreement for Kineret in U.S. theflyonthewall.com |
| 08:33AM | Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S. Thomson Reuters ONE |
| 08:32AM | InPlay: Savient Pharma and Sobi announce co-promotion agreement for Kineret (anakinra) in the U.S. Briefing.com |
| 08:30AM | Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S. PR Newswire |
| 14-Feb-13 08:20AM | Sharp Increase in FDA Drug Approvals a Major Factor in Biotech Industry's Success Marketwire |
| 11-Feb-13 01:58PM | 5 Medical Stock Losers From Last Week With High Short Ratios at Seeking Alpha |
| 23-Jan-13 08:20AM | Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash Marketwire |
| 13-Jan-13 03:04PM | Savient Pharma: The Ultimate Biotech Option at Seeking Alpha |
| 06:34AM | Dendreon: Foolish Management Review at Motley Fool |
| 10-Jan-13 04:03PM | Savient Pharmaceuticals' CEO Presents at 31st Annual J.P. Morgan Healthcare Conference (Transcript) at Seeking Alpha |
| 08-Jan-13 04:27PM | SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 11:43AM | InPlay: Savient Pharma: KRYSTEXXA (pegloticase) receives European Commission Marketing Authorization for the treatment of certain patients with chronic tophaceous gout Briefing.com |
| 11:42AM | Savient's KRYSTEXXA® (pegloticase) Receives European Commission Marketing Authorization for the Treatment of Certain Patients with Chronic Tophaceous Gout PR Newswire |
| 08:30AM | Savient Pharmaceuticals Announces the Election of Genzyme CEO Dr. David Meeker to Its Board of Directors PR Newswire |
| 04-Jan-13 08:30AM | Savient Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference PR Newswire |
| 31-Dec-12 10:18AM | SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online -7.89% |
| 10-Dec-12 04:25PM | SAVIENT PHARMACEUTICALS INC Files SEC form 8-K/A, Results of Operations and Financial Condition, Financial Statements EDGAR Online +9.65% |
| 05-Dec-12 08:30AM | Savient Announces the Election of Robert G. Savage to its Board of Directors PR Newswire |
| 30-Nov-12 09:54AM | Friday Sector Leaders: Metals & Mining, Biotechnology Stocks at Forbes +9.09% |
| 20-Nov-12 06:45PM | Savient Pharma: Still Struggling To Grow KRYSTEXXA Sales at Seeking Alpha |
| 16-Nov-12 01:04PM | SAVIENT PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 14-Nov-12 04:27PM | SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online |
| 13-Nov-12 08:07AM | InPlay: Savient Pharma reports New data demonstrate KRYSTEXXA; risk significantly reduced the rate of IRs in the post-approval setting, as compared to rates seen during randomized clinical trials Briefing.com |
| 08:00AM | New Data Demonstrate KRYSTEXXA®-Treated Refractory Chronic Gout Patients Experienced Significantly Improved Health-Related Quality of Life PR Newswire |
| 12-Nov-12 08:25AM | Biotech Industry Skyrockets in 2012 as FDA Approval Rate Increases Marketwire |
| 08:20AM | Biotech Industry Skyrockets in 2012 as FDA Approval Rate Increases Marketwire |
| 08:08AM | InPlay: Savient Pharma announces new data published in Annals of the Rheumatic diseases confirm long-term safety and efficacy of KRYSTEXXA for the treatment of refractory chronic gout Briefing.com |
| 08:00AM | New Data Published in Annals of the Rheumatic Diseases Confirm Long-Term Safety and Efficacy of KRYSTEXXA® for the Treatment of Refractory Chronic Gout PR Newswire |
| 10-Nov-12 09:29AM | New Star Analyst Rankings for Savient Pharmaceuticals Inc StarMine |
| 09-Nov-12 09:32AM | New Star Analyst Rankings for Savient Pharmaceuticals Inc StarMine |
| 08-Nov-12 09:36PM | 5 Health-Care Stocks Making Big Moves at Motley Fool -18.57% |
| 04:15PM | SAVIENT PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 02:59PM | Savient Pharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha |
| 11:52AM | 2 Biotech Stocks Experiencing Significant Sell-Offs Investors Should Avoid at Seeking Alpha |
| 10:14AM | Has Savient Pharmaceuticals Become the Perfect Stock? at Motley Fool |
| 07:10AM | InPlay: Savient Pharma misses by $0.11, misses on revs Briefing.com |
| 07:07AM | Q3 2012 Savient Pharmaceuticals, Inc. Earnings Release - Before Market Open CCBN |
| 07:00AM | Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results PR Newswire |
| 25-Oct-12 07:18PM | 3 Health Care Stocks Beating Todays Market at Motley Fool -9.57% |
| 19-Oct-12 10:51AM | InPlay: Savient Pharma confirms it received a positive CHMP opinion for KRYSTEXXA approval in the EU Briefing.com |
| 10:50AM | Savient Receives Positive CHMP Opinion for KRYSTEXXA® Approval in the EU PR Newswire |
| 10:43AM | Pharma Stock Movements After FDA ADCOM And EU EMA Decisions This Week at Seeking Alpha |
| 18-Oct-12 08:32PM | What Moves Biotech Stocks? Ed Arce Has Answers. at Seeking Alpha |
| 16-Oct-12 08:20AM | Biotech Industry Looks to Benefit as FDA Speeds Up Process for Drugs for Critical Diseases Marketwire |
| 15-Oct-12 04:01PM | Savient: Bond Prices, Stock Borrow Rates And Analysts' Target Prices Signal Challenges Ahead at Seeking Alpha |
| 03:48PM | Savient: Bond Prices, Stock Borrow Rates And Analysts' Target Prices Signal Challenges Ahead at Seeking Alpha |
| 11-Oct-12 09:52AM | OCZ Tech: Untouchable For Now at Seeking Alpha |
| 09-Oct-12 01:10PM | Savient Pharmaceuticals May Continue To Run Higher at Seeking Alpha |
| 08:32AM | Savient Pharmaceuticals' Impressive Run May Continue Higher Thomson Reuters ONE |
| 07:30AM | Healthcare Business Report: Pfizers SEC Inquiry, Exact Sciences Potential at Wall St. Cheat Sheet |
| 03:58AM | Healthcare Business Report: Pfizers SEC Inquiry, Exact Sciences Potential at Wall St. Cheat Sheet |
| 08-Oct-12 07:58PM | Healthcare Business Report: Pfizers SEC Inquiry, Exact Sciences Potential at Wall St. Cheat Sheet |
| 05:32PM | Healthcare Business Report: Pfizers SEC Inquiry, Exact Sciences Potential at Wall St. Cheat Sheet |
| 04:04PM | Savient: The Tang Rally Is Over - What's Next at Seeking Alpha |
| 10:41AM | H-P Break-Up Deemed Likely and 4 Stock Analyses Attracting Attention at Wall St. Cheat Sheet |
| 02-Oct-12 09:17AM | Lessons From Biotech's Best Third Quarter Stocks at TheStreet |
| 29-Sep-12 08:35AM | What's Fueling Savient's Run? at Motley Fool |
| 28-Sep-12 04:09PM | Dendreon Gains After Aetna Expands Coverage of Provenge at Bloomberg +12.11% |
| 03:09PM | Dendreon Gains After Aetna Expands Coverage of Provenge at Bloomberg |
| 08:35AM | Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives Act Marketwire |
| 08:27AM | Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives Act Marketwire |
| 08:20AM | Biotech Industry Applauds Introduction of the High Technology Small Business Research Incentives Act Marketwire |
| 27-Sep-12 04:22PM | SAVIENT PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E EDGAR Online -7.85% |
| 26-Sep-12 04:50PM | Savient Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) PR Newswire -10.37% |
| 24-Sep-12 04:13PM | PropThink: Shorts Scramble to Cover as CFO Hire at Savient Bolsters Shares Thomson Reuters ONE +16.80% |
| 10:47AM | Savient Pharmaceuticals hires John Hamill as CFO AP |
| 07:36AM | Savient names John Hamill as CFO theflyonthewall.com |
| 07:32AM | InPlay: Savient Pharma announced the appointment of John Hamill as Senior Vice President & CFO effective today Briefing.com |
| 07:30AM | Savient Pharmaceuticals Names John P. Hamill Chief Financial Officer PR Newswire |
| 21-Sep-12 03:28PM | These 2 Stocks Stopped the Presses at Motley Fool +9.17% |
| 20-Sep-12 01:10PM | Top Biotech Stock Picks for Q4 2012 and Beyond: Interview with UBS Investment Bank Expert Analyst Identifies Equity Winners and Losers Wall Street Transcript +6.51% |
| 07:30AM | Savient Announces Multiple Abstracts Related to KRYSTEXXA® in the Treatment of Refractory Chronic Gout to be Presented at the 2012 ACR/ARHP Annual Meeting PR Newswire |
| 19-Sep-12 07:30AM | Savient Bulls Come Back for More at CNBC |
| 07:02AM | Savient buyers come back for more optionMONSTER |
| 06:10AM | Savient buyers come back for more optionMONSTER |
| 17-Sep-12 06:21PM | The Markets Are Not Going To Crash at Seeking Alpha +13.59% |
| 01:11PM | 3 Best Biotech Stocks For This Week (Part II) at Seeking Alpha |
| 09:53AM | 3 High Beta Liquid Small-Cap Biotechnology Stocks That Are Breaking Out at Seeking Alpha |
